In an attempt to investigate the clinical usefulness of CD64 expression on monocytes for discriminating active TB patients and LTBI subjects, we examined whether a metric incorporating the ML ratio to the CD64 MFI would generate an improved performance, because both values are increased in patients with active TB disease. This evidence concerns the gene FCGR1A and tuberculosis.